An effective, nonsurgical option


  • Clinical development of BOTOX® began with Dr. Alan B. Scott’s search for an alternative to surgery for patients with Strabismus1
  • Strabismus was the first disorder to be treated with Botulinum Toxin Type A1

Clinical improvements

  • 55% of Strabismus patients who received ≥ 1 BOTOX® injections improved to an alignment of ≤ 10 prism diopters when evaluated at ≥ 6 months following injection in an open-label trial (N = 677)
Next Page